30 Day Trial

ORTHOWORLD » Other Articles of Interest

Integra LifeSciences Appoints Mark Augusti as CVP, President, Orthopedics & Tissue Technologies

Mr. Augusti will be responsible for the management of the Spine and Extremities divisions, including strategic direction, portfolio management and evaluation of corporate development opportunities.

Prior to joining Integra, Mr. Augusti served as CEO at Bioventus and spent nine years with Smith & Nephew in a series of leadership roles, most recently as President of Smith & Nephew's Biologic Division. He served as Smith & Nephew's President of the Orthopaedic Trauma & Clinical Therapies Global Business and Senior Vice President and General Manager of the Trauma business. Prior to that, he spent 13 years at GE Medical Systems in various sales, marketing and strategic management roles, both in the U.S. and internationally.

Read the full release online.